RF Microneedling Market, By Device Type (Single-Use RF Microneedling Devices and Reusable RF Microneedling Devices), By Application (Acne and Acne Scars, Fine Lines and Wrinkles, Skin Rejuvenation, Pigmentation and Melasma, Stretch Marks, and Others), By

RF Microneedling Market, By Device Type (Single-Use RF Microneedling Devices and Reusable RF Microneedling Devices), By Application (Acne and Acne Scars, Fine Lines and Wrinkles, Skin Rejuvenation, Pigmentation and Melasma, Stretch Marks, and Others), By Modality (Fractional RF Microneedling, Bipolar RF Microneedling, and Monopolar RF Microneedling), By End User (Dermatology Clinics, Aesthetic Clinics, Home-Use, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


Global RF microneedling market growth is driven by rising adoption of minimally invasive aesthetic procedures. RF microneedling is a non-surgical skin treatment that uses tiny needle electrodes to deliver radiofrequency energy into the skin. This stimulates collagen production and elastin fibers in the dermis layer, thus, tightening and rejuvenating the skin. The treatment is widely being used for reducing signs of aging, treating acne scars, and diminishing the appearance of stretch marks. Furthermore, rising consumer disposable income levels across major markets, increasing focus on physical appearance, growing media influence, and technological advancements in microneedling devices can boost demand for RF microneedling treatments over the forecast period.

Market Dynamics:

Global RF microneedling market growth is driven by rising consumer preference for non-invasive aesthetic treatments due to lesser pain, downtime and risks associated with the procedures. Moreover, widespread promotion and marketing activities by key players can lead to enhanced awareness about the skin tightening and rejuvenating benefits of RF microneedling. However, high product and procedure costs can hamper the market growth. Ongoing R&D efforts to develop more effective yet affordable RF microneedling systems can offer significant opportunities for market players. Expanding medical tourism industries in emerging nations can boost the adoption of RF microneedling globally.

Key features of the study:
  • This report provides in-depth analysis of the global RF microneedling market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global RF microneedling market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Lumenis, Cutera, Endymed Medical, Aesthetics Biomedical, Cartessa, Veroderm Medical Technologies, Stryker, Eclipse Aesthetics, DermaQuip, MDPen, Dermapen World, Bellus Medical, Osada, Inc., George Tiemann & Co., Delasco, MicroAire Surgical Instruments, CONMED Corporation, Medtronic, CANDELA CORPORATION, Sincoheren Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global RF microneedling market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global RF microneedling market
Detailed Segmentation-
  • Device Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Single-Use RF Microneedling Devices
  • Reusable RF Microneedling Devices
  • Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Acne and Acne Scars
  • Fine Lines and Wrinkles
  • Skin Rejuvenation
  • Pigmentation and Melasma
  • Stretch Marks
  • Others
  • Modality Insights (Revenue, USD Bn, 2019 - 2031)
  • Fractional RF Microneedling
  • Bipolar RF Microneedling
  • Monopolar RF Microneedling
  • End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Dermatology Clinics
  • Aesthetic Clinics
  • Home-Use
  • Others
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Lumenis
  • Cutera
  • Endymed Medical
  • Aesthetics Biomedical
  • Cartessa
  • Veroderm Medical Technologies
  • Stryker
  • Eclipse Aesthetics
  • DermaQuip
  • MDPen
  • Dermapen World
  • Bellus Medical
  • Osada, Inc.
  • George Tiemann & Co.
  • Delasco
  • MicroAire Surgical Instruments
  • CONMED Corporation
  • Medtronic
  • CANDELA CORPORATION
  • Sincoheren Ltd.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Leber Congenital Amaurosis Market, By Treatment Type
Global Leber Congenital Amaurosis Market, By Target Gene
Global Leber Congenital Amaurosis Market, By End User
Global Leber Congenital Amaurosis Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Leber Congenital Amaurosis Market, By Treatment Type, 2024-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Gene Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pharmaceutical Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retinal Prosthesis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Assistive Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Leber Congenital Amaurosis Market, By Target Gene, 2024-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 - 2031
Segment Trends
RPE65
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
GUCY2D
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
AIPL1
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
RPGRIP1
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
CEP290
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Other Genes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Leber Congenital Amaurosis Market, By End-User, 2024-2031, (USD Bn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 - 2031
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialized Eye Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ophthalmology Research Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Home Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Leber Congenital Amaurosis Market, By Region, 2019 - 2031, Value (USD Bn)
Introduction
Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Treatment Type, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Target Gene, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Treatment Type, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Target Gene, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Treatment Type, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Target Gene, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Treatment Type, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Target Gene, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Treatment Type, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Target Gene, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Treatment Type, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By Target Gene, 2019 - 2031, Value (USD Bn)
Market Size and Forecast, By End-User, 2019 - 2031, Value (USD Bn)
South Africa
North Africa
Central Africa
8. Competitive Landscape
Novartis
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Biogen
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Spark Therapeutics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GenSight Biologics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Roche
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AbbVie
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Regeneron Pharmaceuticals
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Astellas Pharma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Santen Pharmaceutical
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Orphan Biovitrum
Apellis Pharmaceuticals
Gilead Sciences
Eyenovia
Avexis
Regenxbio
Horizon Therapeutics
Aerie Pharmaceuticals
Ophthotech Corporation
Aldeyra Therapeutics
9. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
10. References and Research Methodology
References
Research Methodology
About us
*Browse 32 market data tables and 28 figures on 'Global Leber Congenital Amaurosis Market' - Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings